US Patent
US11123287 — Orodispersible films having quick dissolution times for therapeutic and food use
Formulation · Assigned to PHARMAFILM Srl · Expires 2033-12-16 · 8y remaining
Vulnerability score
55/100
Moderate — design-around opportunities exist
What this patent protects
This patent protects an orodispersible film free from hydrocolloids for therapeutic or food use, made with specific ingredients in certain weight percentages.
USPTO Abstract
The present invention concerns an orodispersible self-supporting film free from hydrocolloids comprising: a) a film-forming substance consisting of a maltodextrin in an amount comprised between 40 and 80% by weight; b) a plasticizer in an amount comprised between 15 and 55% by weight; e) a surfactant System in an amount comprised between 0.5 and 6% by weight; d) an active ingredient for food or therapeutic use in an amount between 0.05 and 30% by weight, characterised in that it contains a homopolymer or a copolymer of vinyl acetate in a quantity comprised between 2 and 10% by weight where the percentages are calculated on the total weight of said film.
Drugs covered by this patent
- Viagra (Sildenafil Citrate) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.